Blood thinners may raise stroke risk in over-65s with kidney disease

February 14, 2018, University College London
Micrograph showing cortical pseudolaminar necrosis, a finding seen in strokes on medical imaging and at autopsy. H&E-LFB stain. Credit: Nephron/Wikipedia

People over 65 years old may be increasing their stroke risk by taking anticoagulants for an irregular heartbeat if they also have chronic kidney disease, finds a new study led by UCL, St George's, University of London and the University of Surrey.

Based on their findings, published today in the BMJ, the researchers warn that doctors should be more cautious about prescribing anticoagulants, also known as , in this population until more studies can clarify the consequences of doing so.

"Chronic disease is common among older people, and one in three people affected also have , commonly called an - and for that, they typically get prescribed blood thinners to reduce their risk of stroke. We found that in this particular group, their medication seems to do the opposite of its intended effect," said the study's first author, Dr Shankar Kumar (UCL Centre for Medical Imaging).

The researchers estimate that close to half a million people over 65 in the UK have both and atrial fibrillation.

"People with chronic kidney disease tend to have numerous severe complications, including cardiovascular illnesses. As their blood clots more but they also bleed more easily, it is extremely difficult to strike a balance between different treatments," said senior author Professor John Camm, professor of clinical cardiology at St George's, University of London.

"As we found a paradoxical reduced mortality rate alongside increased rates of stroke and major bleeding, this is clearly a very complex area. We strongly call for randomised controlled studies to test the clinical value and safety of drug therapy for people with both atrial fibrillation and chronic kidney disease," said Dr Kumar.

In the population-based, , the researchers used a Royal College of General Practitioners database to identify 4848 people over 65 with chronic kidney disease and newly diagnosed atrial fibrillation, half of whom were on anticoagulants and half were not. The participants were monitored for a median of 506 days.

Over the study period, participants who were taking anticoagulants were 2.6 times as likely as those not on anticoagulants to have a stroke, and 2.4 times as likely to have a haemorrhage. The crude rates for ischaemic (the most common type) were 4.6 per 100 person years for those on anticoagulants, and 1.5 for those not on blood thinners (in other words, if the participants were followed for exactly one year, there would be an estimated total of 4.6 ischaemic strokes per 100 people in the blood thinner group and 1.5 ischaemic strokes per 100 people not on thinners).

Mortality in the anticoagulant group was slightly lower; the researchers speculate it may have been due to a reduced risk of fatal strokes or heart attacks, but they say that more research is needed.

"Our work shows the power of big data in providing real world evidence to study important clinical scenarios. Until more data is available, general practitioners, nephrologists and cardiologists need to weigh up the risks and benefits of giving an anticoagulant and make a decision together with their patient," said co-author Professor David Goldsmith (Guy's and St Thomas' NHS Foundation Trust and St George's, University of London).

Explore further: Study discovers anticoagulant drugs are being prescribed against safety advice

More information: BMJ (2018). DOI: 10.1136/bmj.k342

Related Stories

Study discovers anticoagulant drugs are being prescribed against safety advice

July 17, 2017
A study by researchers at the University of Birmingham has shown that GPs are prescribing anticoagulants to patients with an irregular heartbeat against official safety advice.

New oral anticoagulant drugs associated with lower kidney risks

November 20, 2017
Mayo Clinic researchers have shown a link between which type of oral anticoagulant (blood-thinning medication) a patient takes to prevent a stroke and increased risks of kidney function decline or failure.

Short episodes of abnormal heart rhythm may not increase risk of stroke

October 17, 2016
People with pacemakers or defibrillators who experience only short episodes of an abnormal heart rhythm known as atrial fibrillation have a very low risk of stroke, suggesting that anticoagulants in this group of patients ...

Irregular heartbeat linked to wider range of serious conditions than previously thought

September 6, 2016
An irregular heartbeat (known as atrial fibrillation) is associated with a wide range of serious events, including heart attacks, heart failure, chronic kidney disease, and sudden cardiac death, finds a large study in The ...

Atrial fibrillation patients at highest stroke risk not prescribed necessary medication

March 16, 2016
Nearly half of all atrial fibrillation (AF) patients at the highest risk for stroke are not being prescribed blood thinners by their cardiologists, according to a new study by researchers at University of California, San ...

People with irregular heartbeat should take blood thinners to prevent stroke

February 24, 2014
An updated guideline from the American Academy of Neurology recommends that people with nonvalvular atrial fibrillation, or irregular heartbeat, take oral anticoagulants, a type of blood thinner pill, to prevent stroke. The ...

Recommended for you

New treatment significantly reduces cardiovascular events when combined with statins

November 12, 2018
Statins are the most commonly used treatment for cardiovascular disease. Despite reducing certain risk factors, if triglyceride levels remain high with use of statins, there is still a significant risk for heart attack, stroke ...

Kawasaki disease: One disease, multiple triggers

November 12, 2018
Researchers at University of California San Diego School of Medicine, Scripps Institution of Oceanography, and international collaborators have evidence that Kawasaki Disease (KD) does not have a single cause. By studying ...

Study: How vitamin D and fish oil affect risk of heart attack, stroke and cancer

November 12, 2018
For years, it's remained an open question: What effects do dietary supplements such as high doses of vitamin D or omega-3 fatty acids derived from fish oil have on the risk of diseases such as heart attack, stroke and cancer? ...

Diabetes drug might also ease heart failure risks

November 12, 2018
(HealthDay)—The diabetes drug Farxiga might do double-duty for patients, helping to ward off another killer, heart failure, new research shows.

Updated cholesterol guidelines offer more personalized risk assessment, additional treatment options

November 12, 2018
More personalized risk assessments and new cholesterol-lowering drug options for people at the highest risk for cardiovascular disease (CVD) are among the key recommendations in the 2018 cholesterol guidelines from the American ...

Heart meeting features fish oil, vitamin D, cholesterol news

November 11, 2018
Fish oil, vitamin D, novel drugs, new cholesterol guidelines: News from an American Heart Association conference over the weekend reveals a lot about what works and what does not for preventing heart attacks and other problems.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.